Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 12-2015 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 7,678 | 28,590 |
| Marketable Securities | 0 | 29,980 | 26,790 |
| Other current assets | 0 | 2,314 | 310 |
| TOTAL | $0 | $39,972 | $55,690 |
| Non-Current Assets | |||
| PPE Net | N/A | 508 | N/A |
| Other Non-Current Assets | 0 | 200 | 0 |
| TOTAL | $N/A | $708 | $N/A |
| Total Assets | $0 | $40,636 | $55,690 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 2,980 | 600 |
| Accrued Expenses | 0 | 3,880 | 1,310 |
| Other current liabilities | 0 | 0 | 12,000 |
| TOTAL | $0 | $6,873 | $13,920 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 1,060 | 71,649 | 61,690 |
| TOTAL | $N/A | $71,649 | $61,690 |
| Total Liabilities | $0 | $78,522 | $75,620 |
| Shareholders' Equity | |||
| Common Shares | 0 | 550 | 200 |
| Retained earnings | 0 | -84,941 | -67,710 |
| Other shareholders' equity | 0 | 46,505 | 47,590 |
| TOTAL | $0 | $-37,886 | $-19,920 |
| Total Liabilities And Equity | $0 | $40,636 | $55,700 |